Structural Comparison of Avian Versus Mammalian Influenza Receptor Binding

Introduction

Influenza A viruses infect a wide range of avian and mammalian hosts, and the molecular basis of host range restriction is primarily determined by the binding specificity of the viral hemagglutinin (HA) glycoprotein for sialic acid (SA) receptors on host epithelial cells [1, 2]. Avian influenza viruses (AIV) typically recognize SA moieties linked to galactose by an alpha-2,3 glycosidic bond, whereas mammalian-adapted influenza viruses, including those in swine, equine, and human hosts, preferentially bind SA in an alpha-2,6 linkage [1, 3]. This fundamental difference in receptor tropism governs viral replication efficiency, transmissibility, and the likelihood of cross-species spillover events [2, 4]. Understanding the structural nuances of the HA receptor-binding site (RBS) is therefore essential for veterinary surveillance, risk assessment, and computational modeling of emerging influenza strains.

Biochemical Basis of Sialic Acid Receptor Linkages

Sialic acids are nine-carbon monosaccharides typically found at the terminal ends of glycans on cell surface glycoproteins and glycolipids [3]. The two most relevant linkages for influenza virus infection are SA-alpha-2,3-Gal and SA-alpha-2,6-Gal [1]. The difference in glycosidic bond geometry imposes distinct conformational constraints on the glycan chain. Alpha-2,3 linked glycans adopt a relatively short, more linear conformation, while alpha-2,6 linked glycans are more extended and flexible, often assuming a bent or umbrella-like topology [3, 5].

In avian species, alpha-2,3 linked SA receptors are abundant in the respiratory and intestinal epithelium, with high expression in the trachea and gut of waterfowl and poultry [1, 2]. In contrast, mammalian respiratory tracts, particularly in swine and humans, display a predominance of alpha-2,6 linked SA on ciliated epithelial cells of the upper airways [2, 4]. Swine tracheal epithelium expresses both linkage types, making pigs a potential mixing vessel for reassortment of avian and mammalian influenza viruses [1, 4].

Structural Architecture of the Hemagglutinin Receptor-Binding Site

The HA globular head domain contains a shallow pocket that binds SA receptors [3, 5]. This receptor-binding site is composed of three structural elements: the 130-loop (residues 130-137), the 190-helix (residues 190-198), and the 220-loop (residues 220-229) [1, 3]. These elements form a conserved framework that positions the SA moiety through a network of hydrogen bonds and van der Waals contacts [5].

Key conserved residues include Tyr98, Trp153, His183, and Tyr195, which interact with the SA carboxylate and glycerol side chain [3, 5]. However, the amino acids at positions 190, 226, and 228 are critical determinants of linkage preference [1, 2]. In avian-adapted HA subtypes (e.g., H5, H7), position 190 is typically glutamic acid (E190) and position 226 is glutamine (Q226) [2, 4]. In mammalian-adapted HAs (e.g., human H1, H3), position 190 is often aspartic acid (D190) and position 226 is leucine (L226) [1, 3]. Position 228 in avian HAs is generally glycine (G228), whereas mammalian HAs frequently carry serine (S228) [2, 4].

Key Mutations That Switch Receptor Specificity

Two landmark mutations are consistently associated with the adaptation of avian HA to recognize alpha-2,6 receptors: E190D and G228S in the H1 subtype, and Q226L and G228S in the H2 and H3 subtypes [1, 3]. The E190D substitution changes the electrostatic environment at the 190-helix, reducing repulsion of the extended alpha-2,6 glycan and allowing better accommodation of the bulky Neu5Ac moiety [3, 5]. The G228S mutation introduces a serine side chain that forms an additional hydrogen bond with the SA-galactose linkage, stabilizing the alpha-2,6 bound conformation [2, 4].

Structural studies using X-ray crystallography and cryo-electron microscopy have shown that the Q226L substitution in H3 HA increases hydrophobic interactions near the 220-loop, effectively widening the binding cleft to favor the bent conformation of alpha-2,6 receptors [1, 5]. These mutations do not abolish binding to alpha-2,3 receptors but shift the equilibrium toward dual or preferential alpha-2,6 specificity [2, 3].

Other positions, including 133, 136, 137, and 155, can also influence receptor binding avidity and fine specificity [1, 4]. For example, the N-linked glycosylation site at residue 158-160 can modulate receptor binding by masking the RBS in avian viruses [3].

Implications for Transmission and Zoonotic Risk

The ability of a virus to bind human-type alpha-2,6 receptors is a prerequisite for efficient human-to-human transmission [2, 4]. However, additional adaptations, such as changes in neuraminidase (NA) activity and polymerase complex efficiency, are required for full pandemic potential [1, 3]. In veterinary contexts, the emergence of viruses with dual or altered receptor specificity in poultry and swine populations poses a continuous surveillance challenge [2, 4].

For instance, certain H5N1 highly pathogenic avian influenza (HPAI) viruses have acquired mutations such as Q226L and G228S, enabling them to bind alpha-2,6 receptors while retaining alpha-2,3 affinity [1, 4]. These variants have been detected in naturally infected poultry and wild birds, highlighting the potential for mammalian adaptation [2, 3]. The computational prediction of receptor specificity from HA sequences is now a standard tool in veterinary virology and is integrated into risk assessment frameworks [4, 5].

Computational Analysis and Visualization of Receptor Binding Clefts

Bioinformatics tools enable direct structural comparison of avian and mammalian HA receptor-binding clefts. Sequence alignment and homology modeling can identify key residue differences, while molecular docking simulations predict binding energies for different glycan ligands [5]. Our 3D Protein Viewer allows side-by-side comparison of pre-defined binding clefts from representative avian and mammalian HA structures. Users can rotate and zoom into the 190-helix, 130-loop, and 220-loop regions to visualize the precise steric and electrostatic changes conferred by mutations such as E190D and G228S.

A decision tree for receptor specificity prediction based on HA sequence is provided below.

flowchart TD
    A[HA Sequence], > B{Position 226?}
    B, Q226, > C{Position 228?}
    C, G228, > D[Avian-type: alpha-2,3 preference]
    C, S228, > E[Dual specificity possible]
    B, L226, > F{Position 190?}
    F, E190, > G[Dual specificity possible]
    F, D190 or other, > H[Mammalian-type: alpha-2,6 preference]
    D, > I[Low zoonotic risk in mammals]
    E, > J[Intermediate risk; requires further adaptation]
    H, > K[Higher zoonotic risk; potential for transmission]

This flowchart provides a simplified guide for assessing receptor binding preference from HA sequence data. Additional positions (e.g., 133, 136, 183) should be considered for refined predictions [1, 3, 5].

Conclusion

The structural comparison of avian and mammalian influenza receptor binding reveals a finely tuned molecular interface that governs host range and interspecies transmission. Key mutations in the HA receptor-binding site, particularly E190D, G228S, and Q226L, are critical determinants of linkage preference between alpha-2,3 and alpha-2,6 sialic acids. Computational structural biology tools, including our 3D Protein Viewer and the decision tree above, provide valuable resources for veterinary diagnosticians and researchers monitoring the emergence of potentially pandemic influenza strains in animal populations.

References

[1] Swayne, D.E., Glisson, J.R., McDougald, L.R., Nolan, L.K., Suarez, D.L., and Nair, V.L. (eds.). Diseases of Poultry. 14th ed. Wiley-Blackwell.

[2] Merck Veterinary Manual. 11th ed. Merck & Co., Inc.

[3] Knipe, D.M., and Howley, P.M. (eds.). Fields Virology. 7th ed. Lippincott Williams & Wilkins.

[4] World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Current edition.

[5] Rossmann, M.G., and Rao, V.B. (eds.). Viral Molecular Machines. Springer. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.